The lack of FDA approval also means that definitive safety and efficacy trials are still forthcoming
How is the medication delivered
Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP
In fact, the great majority of the early case reports suggest that the improvement in hematopoiesis seen in pernicious anemia patients after folic acid treatment is temporary, and in time they regress and relapse (46, 12, 15)
Because AOD9604 does not stimulate IGF-1 production and lacks strong GH receptor agonism, it may present a safer alternative for long-term OA treatment [1]
Can I switch forms if my labs improve but symptoms persist